Navigation Links
China Biologic Products Announces Strong 2008 Results
Date:4/1/2009

in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on its website (http://www.sec.gov ). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.



                 CHINA BIOLOGIC PRODUCTS, INC. AND SUBSIDIARIES
         CONSOLIDATED STATEMENTS OF INCOME AND OTHER COMPREHENSIVE INCOME
                 FOR THE YEARS ENDED DECEMBER 31, 2008 AND 2007

                                                   2008              2007

    REVENUES                                   $46,751,160       $32,398,669
    COST OF SALES                               14,040,602         9,945,921
    GROSS PROFIT                                32,710,558        22,452,748

    OPERATING EXPENSES:
           Selling expenses                      2,212,073         4,434,721
           General and administrative
            expenses                             7,684,493         4,651,434
           Research and development
            expenses                             1,166,494           609,178
           Stock-based compensation
            expenses (general and
            administrative)                      1,311,727                --
    TOTAL OPERATING EXPENSES
'/>"/>
SOURCE  China Biologic Products, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
5. China Technology Announces New Chief Financial Officer
6. China Medical Technologies Reports First Quarter Financial Results
7. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
8. China Technology Announces Entry to the Solar Energy Sector
9. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products
10. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
11. China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... Port Washington, NY (PRWEB) May 22, 2013 ... most comprehensive line of accessories for the mobile lifestyle, ... to charge, sync, protect, and manage multiple iPad devices ... design award and the 2012 Good Design award, MultiCharger-X ... utilize the iPad, wherever it is deployed. , ...
(Date:5/22/2013)... New York (PRWEB) May 22, 2013 ... the 3rd Annual Disruptive Innovations to Advance Clinical Trials ... Copley Plaza Hotel in Boston, MA. , Disruptive ... Janssen Pharmaceuticals and more share bold approaches to reduce ... , “Disruptive innovation needs to be big, or ...
(Date:5/22/2013)... BUFFALO, N.Y. , May 22, 2013 /PRNewswire/ ... exclusive license for a patent pending novel genomic ... a molecular diagnostic test that could help in ... (NEPC) prostate cancer.  Neuroendocrine prostate ... adenocarcinoma (PCA) that can arise de novo, but ...
(Date:5/22/2013)... NEW ORLEANS , May 22, 2013  Organogenesis ... medicine, presented new data generated in collaboration with a ... health economics consultancy) demonstrating the significant healthcare resource and ... leg ulcers (VLU) place upon the US healthcare system. ... reveal annual costs of up to $15 billion and ...
Breaking Biology Technology:iLuv Now Shipping the All New MultiCharger-X 2iLuv Now Shipping the All New MultiCharger-X 3Disruptive Innovation Hits Clinical Trials, Dedicated Event Launches 2Empire Genomics Licenses Novel DNA Biomarker for Use in Diagnosing and Creating a Companion Diagnostic Test for Neuroendocrine Prostate Cancer 2Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 2Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 3Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 4
... 25 Encision Inc. ("Encision") (OTC Bulletin Board: ECIA), ... is emerging as a standard of care in minimally-invasive ... Inc. ("Caldera") to represent Caldera,s line of products. ... stress urinary incontinence which is estimated to affect 15 ...
... Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY ... in its U.K. clinical trial to evaluate the ... combination with gemcitabine (Gemzar(R)) in patients with advanced ... principal investigators are Dr. Johann de Bono of ...
... is a true super hero to Senator Katherine Laforge. With stakes higher ... energy crisis that threatens to enslave America to OPEC forever. The message ... that alternative energy can free us from OPEC and put an end to ... ...
Cached Biology Technology:Encision Enters Into Sales Representation Agreement With Caldera Medical 2Oncolytics Biotech(R) Inc. Completes Enrolment in Combination REOLYSIN(R)/Gemcitabine Trial 2Oncolytics Biotech(R) Inc. Completes Enrolment in Combination REOLYSIN(R)/Gemcitabine Trial 3Batman Teams with Senator Katherine Laforge to Help Free America from OPEC 2Batman Teams with Senator Katherine Laforge to Help Free America from OPEC 3Batman Teams with Senator Katherine Laforge to Help Free America from OPEC 4Batman Teams with Senator Katherine Laforge to Help Free America from OPEC 5
(Date:5/22/2013)... (NLST) investigators also conclude that the 20 percent ... tomography (LDCT) versus chest X-ray (CXR) screening previously ... at experienced screening centers in the United States. ... with their patients about the benefits and risks ... in the New England Journal of Medicine ...
(Date:5/22/2013)... Harvard physicists have developed a novel technique that can ... a process that is one of the most important, ... described in a paper in Nature , post-doctoral ... Dr. Melanie Schnell of the Center for Free-Electron Laser ... relies on finely-tuned microwave fields to identify molecular variants ...
(Date:5/22/2013)... Md. (May 22, 2013)The omega 3 fatty acids in ... cardiovascular diseaseso much so that the American Heart Association ... a week, particularly fatty varieties rich in omega 3s. ... a mystery. In a new study, scientists led by ... on this phenomenon by providing evidence that fish oil ...
Breaking Biology News(10 mins):NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 2NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 3Detecting mirror molecules 2Detecting mirror molecules 3Fish oil may help the heart beat mental stress 2
... Electronic products pollute our environment with a number of ... the U.S. alone, an estimated 70% of heavy metals ... TVs getting bigger and cheaper every year, environmental costs ... new Tel Aviv University solution applies a discovery in ...
... scientists claim that a new method of testing ... rapid and non-invasively method of diagnosing degenerative disorders. ... Comparative Neurology , reveals that Magnetic Resonance Spectroscopy ... allowing earlier diagnosis. The diagnosis of ...
... the Entomological Society of America, will feature two plenary ... 12-15, 2010. Christopher Marley, an author and insect ... "insect-phobe" into an aficionado during a speech called "The ... CA in the late 1960,s, where he had a ...
Cached Biology News:'Greening' your flat screen TV 2Research heralds potential for early diagnosis of degenerative brain disorders 2Christopher Marley and James McWilliams to give plenary speeches at Entomology 2010 2
Each Yeast-GFP clone represents an individual S. cerevisiae strain containing an open reading frame with a C-terminal Aequorea Victoria GFP (S65T) fusion tag....
... acid hybridization Preparation Reconstitution: one ... 50 mg ficoll and 50 ... ml of water yields a ... biology Density: 1.00 g/mL (20 ...
Each Yeast-GFP clone represents an individual S. cerevisiae strain containing an open reading frame with a C-terminal Aequorea Victoria GFP (S65T) fusion tag....
...
Biology Products: